相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates
MaryBeth B. Culp et al.
EUROPEAN UROLOGY (2020)
Prostate Cancer Incidence and Survival, by Stage and Race/Ethnicity — United States, 2001–2017
David A. Siegel et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Presenting stage and risk group in men dying of prostate cancer
S. Parimi et al.
CURRENT ONCOLOGY (2020)
Incidence of Death From Unintentional Injury Among Patients With Cancer in the United States
Kunyu Yang et al.
JAMA NETWORK OPEN (2020)
Abiraterone acetate plus prednisone in patients with newly Croatia& diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial
Karim Fizazi et al.
LANCET ONCOLOGY (2019)
Temporal trends, ethnic determinants, and short-term and long-term risk of cardiac death in cancer patients: a cohort study
Mohamed M. Gad et al.
CARDIOVASCULAR PATHOLOGY (2019)
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial
Christos E. Kyriakopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States
Scott P. Kelly et al.
EUROPEAN UROLOGY FOCUS (2018)
Cardiovascular disease risk and androgen deprivation therapy in patients with localised prostate cancer: a prospective cohort study
Reina Haque et al.
BRITISH JOURNAL OF CANCER (2017)
A Surveillance, Epidemiology and End Results (SEER) database malfunction: perceptions, pitfalls and verities
Maxine Sun et al.
BJU INTERNATIONAL (2016)
Causes of death in men with localized prostate cancer: a nationwide, population-based study
Mieke Van Hemelrijck et al.
BJU INTERNATIONAL (2016)
Stroke related to androgen deprivation therapy for prostate cancer: a meta-analysis and systematic review
Fanzheng Meng et al.
BMC CANCER (2016)
Accuracy of Death Certificates and Assessment of Factors for Misclassification of Underlying Cause of Death
Makiko Naka Mieno et al.
JOURNAL OF EPIDEMIOLOGY (2016)
Cause of Death in Korean Men with Prostate Cancer: an Analysis of Time Trends in a Nationwide Cohort
Jinsung Park et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2016)
Increasing incidence of metastatic prostate cancer in the United States (2004-2013)
A. B. Weiner et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2016)
Decrease in Prostate Cancer Testing Following the US Preventive Services Task Force (USPSTF) Recommendations
Jun Li et al.
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2015)
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
Christopher J. Sweeney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Incidence of Second Malignancies for Prostate Cancer
Mieke Van Hemelrijck et al.
PLOS ONE (2014)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies
Erik von Elm et al.
INTERNATIONAL JOURNAL OF SURGERY (2014)
Assessing the utility of cancer-registryprocessed cause of death in calculating cancer-specific survival
Chung-Yuan Hu et al.
CANCER (2013)
Does Comorbidity Influence the Risk of Myocardial Infarction or Diabetes During Androgen-Deprivation Therapy for Prostate Cancer?
Nancy L. Keating et al.
EUROPEAN UROLOGY (2013)
Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial
Gwenaelle Gravis et al.
LANCET ONCOLOGY (2013)
Limitations and Biases of the Surveillance, Epidemiology, and End Results Database
Henry S. Park et al.
CURRENT PROBLEMS IN CANCER (2012)
The accuracy of cancer mortality statistics based on death certificates in the United States
Robert R. German et al.
CANCER EPIDEMIOLOGY (2011)
Androgen-Deprivation Therapy and the Risk of Stroke in Patients With Prostate Cancer
Laurent Azoulay et al.
EUROPEAN UROLOGY (2011)
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. De Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Should Cause of Death From the Death Certificate Be Used to Examine Cancer-Specific Survival? A Study of Patients With Distant Stage Disease
Jennifer L. Lund et al.
CANCER INVESTIGATION (2010)
Absolute and Relative Risk of Cardiovascular Disease in Men With Prostate Cancer: Results From the Population-Based PCBaSe Sweden
Mieke Van Hemelrijck et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The Dark Side of Testosterone Deficiency: III. Cardiovascular Disease
Abdulmaged M. Traish et al.
JOURNAL OF ANDROLOGY (2009)
Impact of Androgen Deprivation Therapy on Cardiovascular Disease and Diabetes
Shabbir M. H. Alibhai et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Low serum testosterone and mortality in older men
Gail A. Laughlin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) prospective population study
Kay-Tee Khaw et al.
CIRCULATION (2007)
Changing patterns in competing causes of death in men with prostate cancer: A population based study
G Lu-Yao et al.
JOURNAL OF UROLOGY (2004)
Intramuscular testosterone esters and plasma lipids in hypogonadal men: A meta-analysis
EA Whitsel et al.
AMERICAN JOURNAL OF MEDICINE (2001)
Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort
CJ Newschaffer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
